BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31612621)

  • 1. Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis - a qualitative analysis.
    Zimmermann HM; Eekman SW; Achterbergh RC; Schim van der Loeff MF; Prins M; de Vries HJ; Hoornenborg E; Davidovich U;
    J Int AIDS Soc; 2019 Oct; 22(10):e25389. PubMed ID: 31612621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DP.
    Jongen VW; Hoornenborg E; van den Elshout MA; Boyd A; Zimmermann HM; Coyer L; Davidovich U; Anderson PL; de Vries HJ; Prins M; Schim van der Loeff MF;
    J Int AIDS Soc; 2021 May; 24(5):e25708. PubMed ID: 33973373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men.
    Jongen VW; Reyniers T; Ypma ZM; Schim van der Loeff MF; Davidovich U; Zimmermann HM; Coyer L; van den Elshout MA; de Vries HJ; Wouters K; Smekens T; Vuylsteke B; Prins M; Laga M; Hoornenborg E
    J Int AIDS Soc; 2021 Aug; 24(8):e25768. PubMed ID: 34382345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam.
    Hoornenborg E; Achterbergh RC; van der Loeff MFS; Davidovich U; van der Helm JJ; Hogewoning A; van Duijnhoven YT; Sonder GJ; de Vries HJ; Prins M;
    J Int AIDS Soc; 2018 Mar; 21(3):e25105. PubMed ID: 29603900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E;
    PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan.
    Wu HJ; Wen-Wei Ku S; Chang HH; Li CW; Ko NY; Strong C
    J Int AIDS Soc; 2021 May; 24(5):e25733. PubMed ID: 34018330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa.
    Laurent C; Yaya I; Cuer B; Sagaon-Teyssier L; Mensah E; Dah TTE; Coulibaly A; Kouamé MJ; Peytavin G; Serrano L; Eubanks A; Traoré I; Diallo F; Riegel L; Rojas Castro D; Dagnra CA; Anoma C; Vuylsteke B; Dembélé Keita B; Spire B;
    Clin Infect Dis; 2023 Aug; 77(4):606-614. PubMed ID: 37052469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of adherence to daily PrEP measured as intracellular tenofovir diphosphate concentrations over 24 months of follow-up among men who have sex with men.
    van den Elshout MA; Hoornenborg E; Coyer L; Anderson PL; Davidovich U; de Vries HJ; Prins M; Schim van der Loeff MF;
    Sex Transm Infect; 2023 Aug; 99(5):303-310. PubMed ID: 37258273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project.
    Reyniers T; Nöstlinger C; Laga M; De Baetselier I; Crucitti T; Wouters K; Smekens B; Buyze J; Vuylsteke B
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):186-194. PubMed ID: 29975211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on Pre-Exposure Prophylaxis Regimens among Men Who Have Sex with Men: A Prospective Cohort Study.
    Wu D; Tao H; Dai J; Liang H; Huang A; Zhong X
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31818006
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men.
    Coyer L; van den Elshout MAM; Achterbergh RCA; Matser A; Schim van der Loeff MF; Davidovich U; de Vries HJC; Prins M; Hoornenborg E; Boyd A;
    EClinicalMedicine; 2020 Dec; 29-30():100650. PubMed ID: 33305198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies.
    Jongen VW; Reyniers T; Schim van der Loeff M; Smekens T; Hoornenborg E; van den Elshout M; Zimmermann H; Coyer L; Kenyon C; De Baetselier I; Davidovich U; de Vries HJC; Prins M; Laga M; Vuylsteke B; Boyd A
    J Int AIDS Soc; 2023 Jul; 26(7):e26133. PubMed ID: 37501262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motives of Dutch men who have sex with men for daily and intermittent HIV pre-exposure prophylaxis usage and preferences for implementation: A qualitative study.
    Bil JP; van der Veldt WM; Prins M; Stolte IG; Davidovich U
    Medicine (Baltimore); 2016 Sep; 95(39):e4910. PubMed ID: 27684827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between daily and on-demand PrEP (pre-exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open-label, crossover trial.
    Kwan TH; Lui GCY; Lam TTN; Lee KCK; Wong NS; Chan DPC; Lee SS
    J Int AIDS Soc; 2021 Sep; 24(9):e25795. PubMed ID: 34473402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.
    Zimmermann HML; Jongen VW; Boyd A; Hoornenborg E; Prins M; de Vries HJC; Schim van der Loeff MF; Davidovich U;
    AIDS; 2020 Dec; 34(15):2295-2304. PubMed ID: 33196494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
    Kimani M; van der Elst EM; Chirro O; Wahome E; Ibrahim F; Mukuria N; de Wit TFR; Graham SM; Operario D; Sanders EJ
    PLoS One; 2021; 16(1):e0244226. PubMed ID: 33465090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.